Abstract:For the immune system to function properly, the activation of leukocytes must be tightly regulated. Failures of immune control mechanisms underlie the aberrant targeting of self‐antigens (i.e. autoimmunity) and the collateral damage of healthy tissues during excessive responses to infectious threats or the unnecessary immune mobilization against innocuous commensal microbes. Foxp3‐expressing CD4+ Regulatory T cells (Tregs) are a major cellular force working to prevent these pathologies of immune dysregulation. These cells characteristically exhibit multiple suppressive function that is absolutely required for the maintenance of immune homeostasis. However, these cells can hamper desirable anti‐tumor immune responses in cancer patients. Accordingly, a relative abundance of Tregs in the tumor microenvironment (TME) is a negative prognostic factor in many cancers. Treg‐depleting or antagonizing strategies show promise as potential interventions capable of unleashing anti‐tumor immunity from suppression. The characteristic gene expression and suppressive function of Tregs depend considerably on the stable expression and activity of the transcription factor FOXP3. While transcriptional regulation of the Foxp3gene has been studied in depth, both the expression and function of this factor are also modulated at the protein level. However, the molecular players involved in posttranslational FOXP3 regulation are just beginning to be elucidated. We have found that in the absence of the E3 ligase TRAF6 Tregs were dysfunctional in vivo. In these studies, mice with Treg‐restricted deletion of TRAF6 were highly resistant to implanted tumors and displayed enhanced anti‐tumor immunity. We further determined that FOXP3 undergoes lysine‐63 linked (K63) ubiquitination at lysine 262, and this posttranslational modification was mediated by TRAF6. When deprived of TRAF6 activity or rendered insensitive to K63 ubiquitination, FOXP3 displayed aberrant, perinuclear accumulation and disrupted regulatory function. Thus, K63 ubiquitination by TRAF6 ensures proper localization of FOXP3 and facilitates the transcription factor's gene‐regulating activity in Tregs. These results implicate TRAF6 as a key, hitherto unappreciated posttranslational facilitator of FOXP3 stabilization and Treg suppressive function that may be targeted by novel tolerance‐breaking immunotherapies to improve anti‐tumor immunity and combat disease progression in cancer patients.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

TRAF6 Enhances PD-L1 Expression Through YAP1-TFCP2 Signaling in Melanoma

TRAF6 modulates PD-L1 expression through YAP1-TFCP2 signaling in melanoma

TRAF6 regulates autophagy and apoptosis of melanoma cells through c-Jun/ATG16L2 signaling pathway

TRAF6 Regulates YAP Signaling by Promoting the Ubiquitination and Degradation of MST1 in Pancreatic Cancer

Targeting XPO6 Inhibits Prostate Cancer Progression and Enhances the Suppressive Efficacy of Docetaxel

TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host

TRAF6 Regulates Melanoma Invasion and Metastasis Through Ubiquitination of Basigin

1222 TRAF6 Regulates Autophagy and Apoptosis of Melanoma Cells Through C-Jun/atg16l2 Signaling Pathway

TRAF6 Activates Fibroblasts to Cancer-Associated Fibroblasts through FGF19 in Tumor Microenvironment to Benefit the Malignant Phenotype of Melanoma Cells

TRAF6-overexpressing dendritic cells loaded with MUC1 peptide enhance anti-tumor activity in B16-MUC1 melanoma-bearing mice

The OX40-TRAF6 Axis Promotes CTLA-4 Degradation to Augment Antitumor CD8 + T-cell Immunity

1225 WITHDRAWN

TRAF6 Restricts P53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression.

TRAF6 is Over-Expressed in Pancreatic Cancer and Promotes the Tumorigenicity of Pancreatic Cancer Cells

TRAF6 Inhibits Colorectal Cancer Metastasis Through Regulating Selective Autophagic CTNNB1/β-catenin Degradation and is Targeted for GSK3B/GSK3β-mediated Phosphorylation and Degradation.

TRAF6 directs FOXP3 localization and facilitates regulatory T-cell function through K63-linked ubiquitination.

Data from YAP is Essential for Treg-Mediated Suppression of Antitumor Immunity

TRAF6 is Upregulated in Colon Cancer and Promotes Proliferation of Colon Cancer Cells

TRAF6 promotes chemoresistance to paclitaxel of triple negative breast cancer via regulating PKM2‐mediated glycolysis

YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity.

The E3 Ligase TRAF6 Directs FOXP3 Localization and Facilitates Treg Function Through K63‐type Ubiquitination